BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, de Boer A, Verhoef TI, van der Meer FJ, Le Cessie S, Maitland-van der Zee AH, Barallon R, de Boer A, Daly A, Maitland-van der Zee A, Redekop K, Stingl J, Manolopoulos VG, Rosendaal FR, Wadelius M. Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands. Thrombosis Research 2015;136:94-100. [DOI: 10.1016/j.thromres.2015.04.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez-Covarrubias V, Urena-Carrion J, Villegas-Torres B, Cossío-Aranda JE, Trevethan-Cravioto S, Izaguirre-Avila R, Fiscal-López OJ, Soberon X. Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol. Front Pharmacol 2017;8:863. [PMID: 29218011 DOI: 10.3389/fphar.2017.00863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39:1330-93. [PMID: 29562325 DOI: 10.1093/eurheartj/ehy136] [Cited by in Crossref: 935] [Cited by in F6Publishing: 657] [Article Influence: 311.7] [Reference Citation Analysis]